Pune-based Mylab Discovery Solutions recently announced the commercial launch of its COVID-19 self-test kit, CoviSelf. It has received approval from the Indian Council for Medical Research (ICMR) and can be self-administered by citizens at home.

This indigenous test kit will be distributed to 95% of the PIN codes in the county and will be available over-the-counter at pharmacies and drugstores across India.

Individuals can also order it online through India’s homegrown e-commerce marketplace, Flipkart. To ensure safe deliveries, Flipkart also offers contactless payments for consumers and will leverage its safe and sanitized supply chain.

The company will roll out 1 million self-test kits starting today and based on consumer demand, it will make 7 million units available per week. The product should be available in retail within 2-3 days. The company plans to make the products available on the Government e-marketplace (GEM).

Priced at Rs 250, CoviSelf can be used by individuals with or without symptoms and immediate contacts of confirmed cases as per the ICMR guidelines. Designed as the mid-nasal swab test, it can detect positive results in just 15 mins. Each unit contains a testing kit, instructions to use (IFU) leaflet and a bag to safely dispose of after testing.